Autor: |
Zavalishin IA, Peresedova AV, Stoĭda NI, Rebrova Oi, Zakharova MN, Adarcheva LS, Niazbekova AS, Askarova LSh, Baĭdina EV |
Jazyk: |
ruština |
Zdroj: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2006; Vol. Spec No 3, pp. 111-5. |
Abstrakt: |
A comparative analysis of efficacy and tolerability of such immunomodulating compounds as rebif 22-mcg and copaxone used in the treatment of multiple sclerosis is presented. The analysis was based on the data obtained in the 2-year study of copaxone (145 patients) and rebif 22-mcg (74 patients) therapy carried out in the Neurology Institute, Russian Academy of Medical Sciences. |
Databáze: |
MEDLINE |
Externí odkaz: |
|